Citrate phosphate dextrose adenine (CPDA-1) can be sampled from blood collection bags in a multi-dose manner

Cheryl M Stout1, Jessie M Campanile2, S Emmanuelle Knafo1

  • 11Department of Avian and Exotics, Red Bank Veterinary Hospital, Tinton Falls, NJ.

Insights

Citrate phosphate dextrose adenine (CPDA-1) blood collection bags remain sterile for up to 20 days when sampled aseptically, supporting multi-dose use and reducing waste.

Area of Science:

  • Transfusion Medicine
  • Microbiology
  • Blood Banking

Background:

  • Multi-dose sampling from blood collection bags is common practice.
  • Maintaining the sterility of anticoagulant solutions is crucial for patient safety.
  • Citrate phosphate dextrose adenine (CPDA-1) is a widely used anticoagulant.

Purpose of the Study:

  • To assess the sterility of CPDA-1 anticoagulant in blood collection bags when subjected to multi-dose sampling.
  • To determine the impact of storage temperature on the sterility of CPDA-1 over time.

Main Methods:

  • 10 CPDA-1 blood collection bags were stored at 24°C or 5°C for 30 days.
  • Aseptic 1.0 mL aliquots were withdrawn every 5 days for bacterial culture and every 10 days for fungal culture.
  • Cultures were analyzed for microbial growth.

Main Results:

  • Two positive microbial isolates were identified: Bacillus on day 0 and Candida on day 30.
  • These isolates are suspected to be due to post-sampling contamination.
  • All other samples remained negative for microbial growth.

Conclusions:

  • CPDA-1 blood collection bags can be safely used in a multi-dose manner for up to 20 days if samples are obtained aseptically.
  • This supports the clinical practice of multiple withdrawals from a single bag, minimizing discard.
Abstract

Related Concept Videos